Company intelligence / Profile preview

TheVax Genetics Vaccine Co., Ltd.

Taipei, Taipei City, Taiwanlinkedin.com ↗

Ownership: Private
Employees: ~7
Development stage: Preclinical

Overview

The company has developed therapeutic vaccines targeting cervical cancer, precancerous lesions, and hepatitis B. Its lead HBV vaccine program has entered first-in-human clinical trials, leveraging a proprietary technology platform to accelerate process development and cGMP manufacturing[2].

Therapeutic areas: OncologyInfectious Diseases
Modalities: Therapeutic vaccines (monovalent and multivalent)Immunotherapy (platform not explicitly named)
Industry: Biotech

Drug pipeline

1 asset

TVGV-1

Partnerships

Biotechpharma UAB – CDMO partner for cGMP production of the THEVAX HBV vaccine entering first-in-human trials [2].

Beyond the preview

Go deeper on TheVax Genetics Vaccine Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TheVax Genetics Vaccine Co., Ltd..

Explore the full profile